sameAs
P279
Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets?Hunger for iron: the alternative siderophore iron scavenging systems in highly virulent YersiniaIvermectin versus albendazole or thiabendazole for Strongyloides stercoralis infectionSingle-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuumIdentifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysisComparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studiesCarcinogenicity of saccharinRisk impact of edoxaban in the management of stroke and venous thromboembolismEdoxaban in venous thromboembolism and stroke prevention: an appraisalComparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisNegative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic WindowProfile of paritaprevir/ritonavir/ombitasvir plus dasabuvir in the treatment of chronic hepatitis C virus genotype 1 infectionRationale and clinical utility of the darunavir-cobicistat combination in the treatment of HIV/AIDSIs Levamisole-Induced Vasculitis a Relegated Diagnostic Possibility? A Case Report and Review of LiteratureNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsStudy of Protein Biomarkers of Diabetes Mellitus Type 2 and Therapy with Vitamin B1Efficacy and safety of acotiamide for the treatment of functional dyspepsia: systematic review and meta-analysisThe risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studiesNew oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similaritiesUpdate on the development of lurasidone as a treatment for patients with acute schizophreniaChemotherapy and chemoprevention by thiazolidinedionesAcetazolamide: a second wind for a respiratory stimulant in the intensive care unit?Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid LeukemiaDasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerationsDosing Recommendations for Concomitant Medications During 3D Anti-HCV TherapyRole of dietary protein and thiamine intakes on cognitive function in healthy older people: a systematic reviewDiagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisFixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products.Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new casesNew dosing schedules of dasatinib for CML and adverse event managementFirst-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report.Management of hyperuricemia in gout: focus on febuxostat.Phase III trials of new oral anticoagulants in the acute treatment and secondary prevention of VTE: comparison and critique of study methodology and results.Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients.Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic ReviewsConcomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetesEdoxaban: an update on the new oral direct factor Xa inhibitor.
P921
Q21032531-2C103990-DA68-4316-AFD3-5D55872804F4Q21131302-AFA73E57-A52A-42FC-B3E1-0FAAA2177885Q24186446-160A9BCA-2AB4-437E-BFAA-0B7715454564Q24594356-e56250aa-47d4-c9e7-b0da-e51094ec63bfQ24627908-80CC813A-9497-4831-AAB2-42D4811FFDA1Q24632655-37F6E78E-BA8F-4BA9-BB90-CED724473BB2Q24671852-22156FA4-F1BA-4DD4-A295-7EE3A06550C5Q26738846-F1BE78BF-E8F4-4E4B-A909-BA8A200C6E2EQ26751263-1756F534-91A7-4563-82E7-89B3199CC082Q26771581-A3FAB8D5-8644-4432-B7F2-C5D2BC47EFBDQ26775243-CA2DCE49-5425-4D0F-BC0E-7F3D9D13D876Q26775825-80EC6425-6D73-474B-BF16-88693CAC8892Q26777251-447E3ADB-16EC-4531-85DE-71B23D368927Q26781092-8A9924B7-E63B-4D90-A9E5-8F79FC7EE052Q26796448-72101264-94CD-40ED-B1FF-DC93F6612EADQ26798146-72DFD0D1-6822-4298-BD65-6E5CDC3F48EBQ26991792-70A5A994-9800-439F-A201-9A46FEEE1BE0Q26999933-096A058F-CD06-425E-B34E-7F3F48A75D79Q27001528-BA988901-93AF-44B6-B4D4-75C34DA262E7Q27009585-E07C91D6-53F6-40D0-860F-FD28D061FE9AQ27011352-4E0F8252-B016-4A43-8571-55998198BDB3Q27023730-EE5A7F1F-87BF-41A0-BEC6-8C7FDD5D3709Q28072058-923CBBB3-3B64-4B56-8C1A-A54D814164CAQ28079372-EBC9424E-2EB0-40ED-BC1B-A1C428186039Q28080752-85F6C043-60C2-4798-B74C-B3F21A5A5EE4Q28082301-2FBBC8DB-0A19-4A98-A87C-A082AF772BE3Q28088506-8FAF4522-C05F-4524-B335-C423FD8500A1Q30588260-CF82CF03-590F-4C5D-9B8A-B32119F7AD43Q30642086-21EC2F9D-F8FA-4C0B-B67F-9B5397D01C69Q33383407-0E315D57-28A3-46D5-8CCA-21359AD3840EQ33392977-40E9B786-CEA5-488F-B3B4-D76E932925BCQ33427048-8364419C-4715-4C03-881D-7C1E9340781BQ33476850-0D580F25-620D-4B60-A2C4-B570FFABF7DBQ33568852-B09BA6E1-37C1-4766-B7F0-C2D3A02AA4D1Q33635542-81DF8BEC-9C9B-4A97-9870-8A758CE57402Q33663404-999E27A8-47E4-4F77-B9B1-E6597A131926Q33686312-72C11A20-561C-4751-9A7C-022B2E7F360AQ33716263-C46A20A4-E9C2-4F4B-9D22-97BC7787307EQ33797616-A88FD0B5-5C82-423E-BE00-B6C67E711BA9Q33935409-D830CED7-5443-47EE-BD7F-35EFC452B79B
P921
description
heterocyclic compounds having ...... itrogen and sulfur heteroatoms
@en
każdy związek heterocykliczny ...... z heteroatomami azotu i siarki
@pl
stofklasse
@nl
name
Thiazole
@de
thiazole (groupe)
@fr
thiazoles
@en
thiazool
@nl
tiazol
@pl
tiazoloj
@eo
type
label
Thiazole
@de
thiazole (groupe)
@fr
thiazoles
@en
thiazool
@nl
tiazol
@pl
tiazoloj
@eo
altLabel
Isothiazole
@de
thiazole
@en
tiazole
@pl
prefLabel
Thiazole
@de
thiazole (groupe)
@fr
thiazoles
@en
thiazool
@nl
tiazol
@pl
tiazoloj
@eo
P486
P683
P1417
science/thiazole
P373
P3827
P486
P672
D02.886.675
D03.383.129.708